Location: Start
Richard Complete

Take the challenge to discover the allergen causing his symptoms.

the rules

The allergen responsible for Richard's symptoms is somewhere in his house or backyard. Explore the property to find it.

You will be asked a different allergy related question in each of the seven locations in the house. Answer each correctly to eliminate all the suspects and solve the case.

Once you've completed the investigation, register for ZYRTEC® ZIPLINETM member status. You'll receive expedited processing on your orders.

ZYRTECT® ZIPLINETM membership entitles you to complimentary expedited processing on patient education materials and samples, early access to new patient education materials, and a dedicated customer service number at our Customer Care Center.

Richard is currently using loratadine and is wondering about potential differences.


In controlled clinical trials, at 4 weeks, SAR patients treated with ZYRTEC® had approximately what % reduction in total symptom severity score (TSSC) compared to their baseline?

  • 15%-25%
  • 30%-40%
  • 40%-50%
  • 50%-70%

Next Room
Richards Bacteria


You solved Richard’s case.

Outdoor fungi in the [GAZEBO] is a likely culprit. With ZYRTEC®, he’ll be able to find consistent relief from SAR.

Now that your first case is solved,
register for ZYRTEC® ZIPLINETM status
and you'll get expedited processing on ZYRTEC® samples.

Q: 6 of 7

Lorem quam publici contem acepoenam furicae autum nocae qua te, tem sum eriverf iterfenti?


*ZYRTEC® 10 mg starts working at hour 1 and Claritin® starts working at hour 3 based on first dose on the first day of a 2-day study in 2 pollen chamber studies. Primary endpoint measured mean improvement from baseline in major symptom complex (MSC) severity score. MSC symptoms included runny nose, sniffles, itchy nose, nose blows, sneezes, and watery eyes. † The environmental exposure unit (EEU) is an indoor chamber used to expose large groups of subjects to controlled levels of pollen comparable to those experienced outdoors during peak allergy season and can be replicated regardless of time of year. The EEU is a validated, standard method of determining onset of action and duration of anti-allergic treatments. References: 1. Day JH, Briscoe M, Widitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. 1998;101:638-645. 2. Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B. Comparative onset of action and symptom relief with cetirizine, loratadine,or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Ann Allergy Asthma Immunol. 2001;87:474-481.

Gathering patient records